Oncogene-induced production of ROS promotes the initiation and progression of thyroid cancer by enhancing the activation of major signaling pathways triggered by oncogenes (NRAS [15–17], PTEN [18]), forming a vicious cycle that propels its pathogenesis. The gene discussed is PTEN; the disease is thyroid gland carcinoma.